TNNI3 and stage 5 chronic kidney disease: Patients with CKD have elevated cTnT and cTnI levels because of the reduced excretion from the kidney [38], however, in CKD, cardiac troponins can predict cardiovascular and all-cause mortality rates in patients with mild-to-moderate CKD or end-stage renal disease.